ESC Premium Access

A novel biomarker-based risk score to predict death in patients with atrial fibrillation: Insights from the ARISTOTLE and RE-LY trials

Congress Presentation

About the speaker

Associate Professor Ziad Hijazi

Uppsala University, Uppsala (Sweden)
4 presentations
0 follower

4 more presentations in this session

State of the Art: stroke risk prediction in atrial fibrillation

Speaker: Doctor I. Savelieva (London, GB)


Female sex is a risk modifier - not a risk factor - for stroke risk assessment in atrial fibrillation: Using a CHA2DS2-VA score rather than CHA2DS2-VASc

Speaker: Mr P. Nielsen (Aalborg, DK)


Changes in thromboembolic risk profile and antithrombotic therapy use over a decade: a comparison of Euro Heart Survey on AF and EURObservational research programme AF pilot registry

Speaker: Doctor M. Proietti (Milan, IT)


Biomarkers for stroke risk prediction in atrial fibrillation

Speaker: Professor J. Oldgren (Uppsala, SE)


Access the full session

Stroke risk prediction in atrial fibrillation

Speakers: Associate Professor Z. Hijazi, Doctor I. Savelieva, Mr P. Nielsen, Doctor M. Proietti, Professor J. Oldgren

About the event


ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb